KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Dec 2024 value amounting to $17.7 million.

  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 8.54% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 8.54%. This contributed to the annual value of $17.7 million for FY2024, which is 1.64% up from last year.
  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) amounted to $17.7 million in FY2024, which was up 1.64% from $17.4 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $170.5 million during FY2021, and its lowest value of $17.0 million during FY2022.
  • In the last 3 years, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $17.4 million in 2023 and averaged $17.4 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) plummeted by 90.00% in 2022 and then grew by 2.06% in 2023.
  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $168.8 million in 2020, then grew by 1.03% to $170.5 million in 2021, then crashed by 90.00% to $17.0 million in 2022, then rose by 2.06% to $17.4 million in 2023, then rose by 1.64% to $17.7 million in 2024.